Navigation Links
'Scaffold' Could One Day Repair Damaged Hearts
Date:11/7/2008

It's the first to match structural, mechanical properties of heart tissue, scientists say

FRIDAY, Nov. 7 (HealthDay News) -- A biological scaffold that can help repair damaged hearts and could also be used to engineer other tissues has been developed by Massachusetts Institute of Technology researchers and colleagues.

The accordion-like, honeycomb scaffold is designed to be seeded with living heart cells or stem cells in order to treat congenital heart defects or aid the recovery of tissue damaged by a heart attack. As the scaffold is gradually absorbed into the body, it leaves behind new tissue, the researchers said.

The scaffold is the first specifically created to match the structural and mechanical properties of heart tissue, giving it a number of advantages over previous scaffolds designed for heart tissue engineering, according to the MIT team.

The general approach used in creating the heart scaffold has applications for other types of engineered tissues.

"In the long term, we'd like to have a whole library of scaffolds for different tissues in need of repair," Lisa E. Freed, a principal research scientist in the Harvard-MIT Division of Health Sciences and Technology, said in an MIT news release.

Each scaffold could be tailor-made with tissue-specific structural and mechanical properties, she said.

"We're already on the way to a few other examples," Freed said.

The research was published in the Nov. 2 online edition of the journal Nature Materials.

More information

The U.S. National Heart, Lung, and Blood Institute has more about cardiac rehabilitation.



-- Robert Preidt



SOURCE: Massachusetts Institute of Technology, news release, Nov. 2, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Pediatricians Could Help Screen for Alcohol Abuse in Home
2. Could It Be? A 100 Calorie Twinkie(R)?
3. Anti-VEGF drugs for retinal diseases could have serious side effects, scientists caution
4. Anti-VEGF Drugs for Retinal Diseases Could Have Serious Side Effects, Scientists Caution
5. Earlier Vaccination Could Cut Whooping Cough Deaths
6. Opt out system could solve donor organ shortage, says researcher
7. LegalView Reports on Rare Traumatic Brain Injury Condition That Could Cause Complete Paralysis of A Victim
8. End of Daylight Saving Time Could Be Heart-Wrenching
9. Flu Vaccine Could Prevent 357,000 Deaths in Pandemic
10. Researchers find new chemical key that could unlock hundreds of new antibiotics
11. Tests Could Predict Benefit From Cancer Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... ... March 22, 2017 , ... ... leading digital and print media enterprise focused on cancer patients, cancer centers and ... released a special 12-part educational video series, “No Ifs, Ands, or Butts,” that ...
(Date:3/22/2017)... ... 22, 2017 , ... The Rett Syndrome Research Trust (RSRT) ... that afflicts 350,000 individuals worldwide. Rett Syndrome is caused by alterations in ... females. Following a normal infancy, Rett Syndrome takes effect in toddlerhood depriving ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... to its Department of Orthopedic Surgery, Division of Hand, Upper Extremity and Microvascular ... surgery. She is board-certified in both Orthopedics and Hand Surgery. , ...
(Date:3/22/2017)... ... March 22, 2017 , ... Intrinsic Imaging, ... therapeutic experience and operational excellence in oncology clinical trials, proudly announces today that ... treatment of non-small cell lung cancer and small cell lung cancer. , Throughout ...
(Date:3/22/2017)... Norwich, NY (PRWEB) , ... March 22, 2017 , ... ... to communities in the greater Nassau County region, is embarking on a combined charity ... breast cancer. , For the last 25 years, the Great Neck Breast Cancer ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... March 22, 2017 AMRI , a ... been working with the life sciences industry to improve ... 25 years, has been recognized for its excellence as ... as part of the Life Science Leader,s 2017 ... expertise, quality and reliability. "Competing with ...
(Date:3/22/2017)... STOCKHOLM , March 22, 2017 ... biopharmaceutical company developing novel anticancer therapies targeting the ... with Memorial Sloan Kettering Cancer Center to study ... p53 by APR-246. The goal of ... efficacy of APR-246 in combination with multiple other ...
(Date:3/22/2017)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 14.58% during the period ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
Breaking Medicine Technology: